Osaki Y - Search Results

1

Clinical significance of the genotype and core promoter/pre-core mutations in hepatitis B virus carriers.

Hagiwara S, Kudo M, Minami Y, Chung H, Nakatani T, Fukunaga T, Osaki Y, Yamashita Y, Kajimura K. Hagiwara S, et al. Among authors: osaki y. Intervirology. 2006;49(4):200-6. doi: 10.1159/000090789. Epub 2006 Jan 11. Intervirology. 2006. PMID: 16407657

2

Clinical characteristics of NonBNonC- HCC: Comparison with HBV and HCV related HCC.

Hatanaka K, Kudo M, Fukunaga T, Ueshima K, Chung H, Minami Y, Sakaguchi Y, Hagiwara S, Orino A, Osaki Y. Hatanaka K, et al. Among authors: osaki y. Intervirology. 2007;50(1):24-31. doi: 10.1159/000096309. Epub 2006 Nov 24. Intervirology. 2007. PMID: 17164554

3

Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.

Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T. Ikeda K, et al. Among authors: osaki y. Ann Intern Med. 2007 May 1;146(9):649-56. doi: 10.7326/0003-4819-146-9-200705010-00008. Ann Intern Med. 2007. PMID: 17470833

4

High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.

Marusawa H, Osaki Y, Kimura T, Ito K, Yamashita Y, Eguchi T, Kudo M, Yamamoto Y, Kojima H, Seno H, Moriyasu F, Chiba T. Marusawa H, et al. Among authors: osaki y. Gut. 1999 Aug;45(2):284-8. doi: 10.1136/gut.45.2.284. Gut. 1999. PMID: 10403743 Free PMC article.

5

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Kudo M, Chung H, Osaki Y. Kudo M, et al. Among authors: osaki y. J Gastroenterol. 2003;38(3):207-15. doi: 10.1007/s005350300038. J Gastroenterol. 2003. PMID: 12673442 Review.

6

Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel.

Chung H, Kudo M, Kumada T, Katsushima S, Okano A, Nakamura T, Osaki Y, Kohigashi K, Yamashita Y, Komori H, Nishiuma S. Chung H, et al. Among authors: osaki y. J Gastroenterol. 2003;38(9):877-9. doi: 10.1007/s00535-003-1156-1. J Gastroenterol. 2003. PMID: 14569445

7

[Comparison of treatment methods for hepatocellular carcinoma--based on JIS score].

Kudo M, Chung H, Osaki Y, Kasugai H, Oka H, Seki T. Kudo M, et al. Among authors: osaki y. Gan To Kagaku Ryoho. 2004 Dec;31(13):2100-4. Gan To Kagaku Ryoho. 2004. PMID: 15628751 Review. Japanese.

8

Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T. Kudo M, et al. Among authors: osaki y. Hepatology. 2004 Dec;40(6):1396-405. doi: 10.1002/hep.20486. Hepatology. 2004. PMID: 15565571

9

A proposal of the modified liver damage classification for hepatocellular carcinoma.

Chung H, Kudo M, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y. Chung H, et al. Among authors: osaki y. Hepatol Res. 2006 Feb;34(2):124-9. doi: 10.1016/j.hepres.2005.10.009. Epub 2005 Dec 27. Hepatol Res. 2006. PMID: 16377236

10

Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.

Wada M, Marusawa H, Yamada R, Nasu A, Osaki Y, Kudo M, Nabeshima M, Fukuda Y, Chiba T, Matsuda F. Wada M, et al. Among authors: osaki y. J Viral Hepat. 2009 Jun;16(6):388-96. doi: 10.1111/j.1365-2893.2009.01095.x. Epub 2009 Feb 5. J Viral Hepat. 2009. PMID: 19200137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

653 results

Search Page

Filters